AlphaYouOM
Insider buying
Opaleye Management Inc. bought $32K of Grace Therapeutics, Inc. (GRCE) stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 15,229 shares of GRCE stock worth $32K, per an SEC Form 4 filed Sep 10, 2026.
It was an open-market purchase.
The trade happened on Sep 8, 2026, 2 days before it was made public.
GRCE has moved -0.9% since the trade date, from $2.12 to $2.10 (Sep 21, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 2 days
- Price since
- -0.9%
- Role
- 10% owner
- Source
- SEC Form 4
More GRCE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.